2024-09-22 - Analysis Report
## AbbVie Inc. (ABBV) Stock Analysis

**Company Overview:** AbbVie Inc. is a global biopharmaceutical company that develops, manufactures, and markets a broad range of pharmaceutical products.

**Performance Analysis:**

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative Return:** ABBV (152.17%) outperformed the S&P 500 (VOO) (132.46%) by 19.71%.
* **Relative Divergence:** ABBV's performance is currently 60.92% away from the minimum/maximum divergence range during the historical period. This means that the stock's performance has been relatively strong compared to the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $193.47
* **5-Day Moving Average:** $193.65
* **20-Day Moving Average:** $195.28
* **60-Day Moving Average:** $185.35

The stock is currently trading slightly below its 5-day and 20-day moving averages, suggesting potential short-term weakness. However, the 60-day moving average is considerably lower, indicating a longer-term upward trend.

**3. Technical Indicators:**

* **RSI:** 43.94 -  This suggests that ABBV is in a neutral zone, neither overbought nor oversold.
* **PPO:** -0.46 - This indicates a bearish trend in the stock, as the 12-period moving average is lower than the 26-period moving average.
* **Delta_Previous_Relative_Divergence:** -8.68 - This indicates a short-term downward trend, as the recent divergence is negative.
* **Expected Return:** 24.44% - This indicates potential for significant returns over the next 5 years based on current investment. 

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-07-25 | 2.65 | 2.57 |
| 2024-04-26 | 2.31 | 2.26 |
| 2024-02-02 | 2.79 | 2.76 |
| 2023-10-27 | 2.95 | 2.86 |
| 2023-07-27 | 2.91 | 2.79 |

ABBV has consistently exceeded earnings expectations in recent quarters. The latest quarter (2024-07-25) saw an EPS of 2.65, exceeding the expected EPS of 2.57. This trend suggests that the company's performance is strong and its earnings are robust. 

**5. Overall Analysis:**

* ABBV's performance has been strong, outperforming the S&P 500 in the long term.
* The stock currently displays short-term weakness, trading below its moving averages, but a longer-term upward trend is present.
* Technical indicators suggest a neutral to bearish sentiment in the short term. 
* However, strong recent earnings and a positive outlook for the future indicate potential for growth.

**6. Conclusion:**

Overall, ABBV appears to be a promising investment opportunity with potential for growth. The company's strong earnings performance and positive outlook make it attractive for investors seeking long-term growth. However, investors should be cautious of the short-term weakness in the stock and monitor its technical indicators closely. 
